enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
2.623
+0.073 (2.84%)
Apr 2, 2025, 3:06 PM EDT - Market open

enVVeno Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-21.82-23.52-24.67-16.53-9.14
Upgrade
Depreciation & Amortization
0.530.550.530.450.38
Upgrade
Loss (Gain) From Sale of Assets
----0.03
Upgrade
Loss (Gain) From Sale of Investments
0.02-0.47-0.05--
Upgrade
Stock-Based Compensation
4.145.28.9960.88
Upgrade
Other Operating Activities
----0.31-0.21
Upgrade
Change in Accounts Payable
0.7-0.180.09-0.830.17
Upgrade
Change in Other Net Operating Assets
-0.41-0.43-0.51-0.630.21
Upgrade
Operating Cash Flow
-16.84-18.86-15.62-11.85-7.68
Upgrade
Capital Expenditures
-0.04-0.03-0.12-0.37-0.18
Upgrade
Investment in Securities
1.37-7.84-34.44--
Upgrade
Investing Cash Flow
1.34-7.87-34.55-0.37-0.18
Upgrade
Short-Term Debt Issued
----0.31
Upgrade
Total Debt Issued
----0.31
Upgrade
Net Debt Issued (Repaid)
----0.31
Upgrade
Issuance of Common Stock
13.6425.79-39.3313.4
Upgrade
Other Financing Activities
---18.27-
Upgrade
Financing Cash Flow
13.6425.79-57.6115.07
Upgrade
Net Cash Flow
-1.87-0.94-50.1745.397.22
Upgrade
Free Cash Flow
-16.88-18.89-15.73-12.22-7.86
Upgrade
Free Cash Flow Per Share
-0.98-1.54-1.66-1.41-6.08
Upgrade
Levered Free Cash Flow
-9.67-10.36-6.33-5.82-3.77
Upgrade
Unlevered Free Cash Flow
-9.67-10.36-6.33-5.82-3.77
Upgrade
Change in Net Working Capital
-0.630.30.151.35-0.85
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q